U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07950046) titled 'High- Versus Low-Density PASCAL Laser Treatment for Proliferative Diabetic Retinopathy' on Nov. 16.

Brief Summary: This study aims to compare the effects of high-density and low-density single-session Pattern Scan Laser (PASCAL) panretinal photocoagulation (PRP) in patients with proliferative diabetic retinopathy (PDR).

Panretinal photocoagulation is a standard treatment for proliferative diabetic retinopathy. However, the number of laser spots applied during a single treatment session varies in clinical practice. This study will investigate whether applying a higher number of laser spots in one session is as safe and effective as ...